Assembly Actions - Lowercase Senate Actions - UPPERCASE |
|
---|---|
Dec 22, 2021 | signed chap.720 |
Dec 10, 2021 | delivered to governor |
Jun 03, 2021 | returned to assembly passed senate 3rd reading cal.1294 substituted for s649a |
Jun 03, 2021 | substituted by a2030 |
May 26, 2021 | ordered to third reading cal.1294 committee discharged and committed to rules |
May 11, 2021 | reported and committed to finance |
Feb 08, 2021 | print number 649a |
Feb 08, 2021 | amend and recommit to health |
Jan 06, 2021 | referred to health |
senate Bill S649A
Signed By GovernorSponsored By
Pete Harckham
(D, WF) 40th Senate District
Archive: Last Bill Status Via A2030 - Signed by Governor
- Introduced
- In Committee
- On Floor Calendar
- Passed Senate
- Passed Assembly
- Delivered to Governor
- Signed by Governor
Your Voice
Actions
Votes
Bill Amendments
S649 - Details
S649 - Sponsor Memo
BILL NUMBER: S649 SPONSOR: HARCKHAM TITLE OF BILL: An act to amend the social services law and the public health law, in relation to medication for the treatment of substance use disorders PURPOSE: This legislation will expand access to medications that treat substance use disorders. SUMMARY OF SPECIFIC PROVISIONS: Section one amends subdivision 2 of section 365-a of the social services law by adding a new paragraph (gg) Section two amends subdivision 26-b of section 364-j of the social services law.
S649 - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 649 2021-2022 Regular Sessions I N S E N A T E (PREFILED) January 6, 2021 ___________ Introduced by Sen. HARCKHAM -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT to amend the social services law and the public health law, in relation to medication for the treatment of substance use disorders THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Subdivision 2 of section 365-a of the social services law is amended by adding a new paragraph (gg) to read as follows: (GG) ALL BUPRENORPHINE PRODUCTS, METHADONE OR LONG ACTING INJECTABLE NALTREXONE FOR DETOXIFICATION OR MAINTENANCE TREATMENT OF A SUBSTANCE USE DISORDER PRESCRIBED ACCORDING TO GENERALLY ACCEPTED NATIONAL PROFES- SIONAL GUIDELINES FOR THE TREATMENT OF A SUBSTANCE USE DISORDER. SUCH MEDICATION ASSISTED TREATMENT SHALL NOT BE SUBJECT TO ANY PRIOR AUTHORI- ZATION MANDATE. § 2. Subdivision 26-b of section 364-j of the social services law, as added by section 4 of part B of chapter 69 of the laws of 2016, is amended to read as follows: 26-b. Managed care providers shall not require prior authorization for [an initial or renewal prescription for buprenorphine or injectable naltrexone for detoxification or maintenance treatment of opioid addiction unless the prescription is for a non-preferred or non-formu- lary form of the drug or as otherwise required by section 1927(k)(6) of the Social Security Act] ANY BUPRENORPHINE PRODUCTS, METHADONE OR LONG ACTING INJECTABLE NALTREXONE FOR DETOXIFICATION OR MAINTENANCE TREATMENT OF A SUBSTANCE USE DISORDER PRESCRIBED ACCORDING TO GENERALLY ACCEPTED NATIONAL PROFESSIONAL GUIDELINES FOR THE TREATMENT OF A SUBSTANCE USE DISORDER. § 3. Subdivision 10 of section 273 of the public health law, as added by section 5 of part B of chapter 69 of the laws of 2016, is amended to read as follows: EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
Co-Sponsors
Fred Akshar
(R, C, IP, RFM) 0 Senate District
Samra G. Brouk
(D, WF) 55th Senate District
Robert Jackson
(D, WF) 31st Senate District
S649A (ACTIVE) - Details
S649A (ACTIVE) - Sponsor Memo
BILL NUMBER: S649A SPONSOR: HARCKHAM TITLE OF BILL: An act to amend the social services law and the public health law, in relation to medication for the treatment of substance use disorders PURPOSE: This legislation will expand access to medications that treat substance use disorders. SUMMARY OF SPECIFIC PROVISIONS: Section one amends subdivision 2 of section 365-a of the social services law by adding a new paragraph (gg) Section two amends subdivision 26-b of section 364-j of the social services law. Section three amends subdivision 10 of section 273 of the public health law. Section four sets the effective date.
S649A (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 649--A 2021-2022 Regular Sessions I N S E N A T E (PREFILED) January 6, 2021 ___________ Introduced by Sen. HARCKHAM -- read twice and ordered printed, and when printed to be committed to the Committee on Health -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee AN ACT to amend the social services law and the public health law, in relation to medication for the treatment of substance use disorders THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Subdivision 2 of section 365-a of the social services law is amended by adding a new paragraph (gg) to read as follows: (GG) ALL BUPRENORPHINE PRODUCTS, METHADONE OR LONG ACTING INJECTABLE NALTREXONE FOR DETOXIFICATION OR MAINTENANCE TREATMENT OF A SUBSTANCE USE DISORDER PRESCRIBED ACCORDING TO GENERALLY ACCEPTED NATIONAL PROFES- SIONAL GUIDELINES FOR THE TREATMENT OF A SUBSTANCE USE DISORDER. SUCH MEDICATION ASSISTED TREATMENT SHALL NOT BE SUBJECT TO ANY PRIOR AUTHORI- ZATION MANDATE. § 2. Subdivision 26-b of section 364-j of the social services law, as added by section 4 of part B of chapter 69 of the laws of 2016, is amended to read as follows: 26-b. Managed care providers shall not require prior authorization for [an initial or renewal prescription for buprenorphine or injectable naltrexone for detoxification or maintenance treatment of opioid addiction unless the prescription is for a non-preferred or non-formu- lary form of the drug or as otherwise required by section 1927(k)(6) of the Social Security Act] ANY BUPRENORPHINE PRODUCTS, METHADONE OR LONG ACTING INJECTABLE NALTREXONE FOR DETOXIFICATION OR MAINTENANCE TREATMENT OF A SUBSTANCE USE DISORDER PRESCRIBED ACCORDING TO GENERALLY ACCEPTED NATIONAL PROFESSIONAL GUIDELINES FOR THE TREATMENT OF A SUBSTANCE USE DISORDER. EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted.
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.